Amount Raised
$25M
Round Type
Series A
Date Raised
Jan 13, 2026
Open roles — actively hiring
Software EngineerProduct ManagerSales LeadMarketing+ 3 more
Get the founder's verified email + all open roles
Find my next client →About Converge Bio
Converge Bio — The Generative AI Lab for the Life Sciences operates in the biotechnology research sector and was founded in 2024. The company recently raised $25M in a Series A round (Jan 13, 2026), positioning the team to scale go-to-market, hire across functions, and evaluate new vendors over the coming quarter.
Why this raise matters
Converge Bio just closed $25M in Series A funding — which means they're actively scaling their team, upgrading their tech stack, and looking for vendors who can help them move fast. Companies at this stage typically make purchasing decisions within 60-90 days of closing a round. If you sell to biotechnology research companies, this is your window to reach out before competitors do.
Frequently asked questions
- How much did Converge Bio raise?
- Converge Bio raised $25M in a Series A round on Jan 13, 2026.
- Who founded Converge Bio?
- Founder information for Converge Bio is available on JustRaised.
- Where is Converge Bio based?
- Location details for Converge Bio are available in the JustRaised database.
- How do I contact the founders of Converge Bio?
- Verified founder emails and LinkedIn profiles for Converge Bio are available on a JustRaised paid plan.